PENMENVY
Meningococcal (Groups A, B, C, W and Y) · KIT · GlaxoSmithKline Biologicals SA
PENMENVY is a kit containing meningococcal (groups a, b, c, w and y). Manufactured by GlaxoSmithKline Biologicals SA.
Key Facts
- Brand Name
- PENMENVY
- Generic Name
- Meningococcal (Groups A, B, C, W and Y)
- NDC Code (Product)
58160-757- Manufacturer
- GlaxoSmithKline Biologicals SA
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125819
- Marketing Start
- 02/14/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is PENMENVY used for?
PENMENVY contains Meningococcal (Groups A, B, C, W and Y). It is a kit taken as directed. Consult your doctor for specific uses.
Is PENMENVY a controlled substance?
PENMENVY is not classified as a controlled substance by the DEA.
What is the generic name for PENMENVY?
The generic name for PENMENVY is Meningococcal (Groups A, B, C, W and Y). There are no other listed brand versions of Meningococcal (Groups A, B, C, W and Y).
What is the NDC code for PENMENVY ?
The NDC (National Drug Code) for PENMENVY is 58160-757, listed by GlaxoSmithKline Biologicals SA.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)